HF
ETNB

HRT Financial’s 89bio ETNB Stock Holding History

HRT Financial’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,115
Closed -$79K – 2733
2024
Q4 		$79K Buy
+10,115
New +$83.3K ﹤0.01% 2062
2024
Q3 		– Sell
-59,202
Closed -$474K – 2623
2024
Q2 		$474K Buy
+59,202
New +$529K ﹤0.01% 1324
2024
Q1 		– Sell
-65,192
Closed -$728K – 2516
2023
Q4 		$728K Buy
+65,192
New +$599K 0.01% 1155
2023
Q1 		– Sell
-56,194
Closed -$715K – 2673
2022
Q4 		$715K Buy
+56,194
New +$506K 0.01% 1198

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's ETNB Position: Q1 2025 in Review

HRT Financial sold out of 89bio (ETNB) in Q1 2025, closing a stake of 10,115 shares — an estimated $79K sold.

HRT Financial first reported a position in ETNB in Q4 2022 and held it in 4 quarters. The position peaked at $728K in Q4 2023. 186 funds tracked by Wall St. Rank hold ETNB as of Q1 2025.

  • HRT Financial reported no remaining 89bio position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 10,115 89bio shares in Q1 2025, an estimated $79K.
  • HRT Financial first reported a position in 89bio in Q4 2022 and held it in 4 quarters.
  • HRT Financial's 89bio position peaked at $728K in Q4 2023.
  • 186 funds tracked by Wall St. Rank held 89bio as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.